Amy Ming Sze Lo
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Amy Ming Sze Lo (盧明詩), a licensed Representative with CE reference AJE176. Currently licensed at 1 firm(s): Nomura Asset Management Hong Kong Limited. Active regulated activities: Type 1 - Dealing in securities; Type 4 - Advising on securities. This person has 22.6 years of SFC licence history. Total licence records on file: 8.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Nomura Asset Management Hong Kong Limited 野村投資管理香港有限公司 |
Rep | Type 1 - Dealing in securities | 2026-05-11 | present |
| Nomura Asset Management Hong Kong Limited 野村投資管理香港有限公司 |
Rep | Type 4 - Advising on securities | 2026-05-11 | present |
| AXA Investment Managers Asia Limited 安盛投資管理亞洲有限公司 |
Rep | Type 1 - Dealing in securities | 2008-05-28 | 2026-03-09 |
| AXA Investment Managers Asia Limited 安盛投資管理亞洲有限公司 |
Rep | Type 4 - Advising on securities | 2008-05-28 | 2026-03-09 |
| AXA Investment Managers Asia Limited 安盛投資管理亞洲有限公司 |
Rep | Type 9 - Asset management | 2008-05-28 | 2015-04-21 |
| AXA Rosenberg Investment Management Asia Pacific Limited 安盛羅森堡投資管理亞太有限公司(以AXARosenbergAsiaPacific;AXAInvestmentManagers名義經營業務) |
Rep | Type 9 - Asset management | 2008-05-28 | 2015-04-21 |
| AXA Rosenberg Investment Management Asia Pacific Limited 安盛羅森堡投資管理亞太有限公司(以AXARosenbergAsiaPacific;AXAInvestmentManagers名義經營業務) |
Rep | Type 1 - Dealing in securities | 2003-10-24 | 2019-01-31 |
| AXA Rosenberg Investment Management Asia Pacific Limited 安盛羅森堡投資管理亞太有限公司(以AXARosenbergAsiaPacific;AXAInvestmentManagers名義經營業務) |
Rep | Type 4 - Advising on securities | 2003-10-24 | 2019-01-31 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Amy Ming Sze Lo during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.